Combipatch and atrophic vulvovaginitis 
Combipatch and atrophic vulvovaginitis Patient Reports February 10, 2012
Combipatch Side Effects Report #6038192-3
Combipatch side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 05, 2009. Female patient, weighting 125.0 lb, was diagnosed with menopause
, cardiovascular event prophylaxis, bone disorder, hot flush, vulvovaginal dryness and was treated with Combipatch. After drug was administered, patient experienced the following side effects: anxiety , atrophic vulvovaginitis, blood cholesterol increased, blood thyroid stimulating hormone increased, blood triglycerides increased, bone density decreased, breast cancer , breast disorder, breast mass. Combipatch dosage: 0.25 MG, UNK. During the same period patient was treated with ESTRADERM, VIVELLE, AYGESTIN. Patient was hospitalized. Patient recovered.Combipatch Side Effects Report #6054939-4
Combipatch side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 23, 2009. Female patient, weighting 125.0 lb, was diagnosed with menopause
, cardiovascular event prophylaxis, bone disorder, hot flush, vulvovaginal dryness and was treated with Combipatch. After drug was administered, patient experienced the following side effects: anxiety , atrophic vulvovaginitis, blood cholesterol increased, blood thyroid stimulating hormone increased, blood triglycerides increased, bone density decreased, breast cancer , breast disorder, breast mass. Combipatch dosage: 0.25 MG, UNK. During the same period patient was treated with ESTRADERM, VIVELLE, AYGESTIN. Patient was hospitalized. Patient recovered.Combipatch Side Effects Report #6068276-5
Combipatch side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 27, 2009. Female patient, weighting 128.0 lb, was diagnosed with menopause
and was treated with Combipatch. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, aspiration breast, atelectasis, atrophic vulvovaginitis, bilirubin conjugated increased, biopsy breast, biopsy breast abnormal. Combipatch dosage: .05MG-0.14 EVERY 3 DAYS. During the same period patient was treated with PREMPRO, PREMARIN, WELLBUTRIN, LEXAPRO, XANAX, TRAZODONE. Patient was hospitalized. Patient recovered.Combipatch Side Effects Report #5396195-6
Combipatch side effect was reported by a Consumer or non-health professional from UNITED STATES on July 20, 2007. Female patient, 52 years of age, was diagnosed with menopausal symptoms and was treated with Combipatch. After drug was administered, patient experienced the following side effects: atrophic vulvovaginitis, breast cancer in situ, cervical dysplasia, cervicitis, cluster headache, hot flush, insomnia, malignant breast lump removal, mastectomy
. Combipatch dosage: 0.5 /0.14 MG/DAY, TIWCE WEEKLY. During the same period patient was treated with PREMPRO, PREMARIN, PROVERA. Patient recovered.Combipatch Side Effects Report #5410813-5
Combipatch side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 03, 2007. Female patient, 52 years of age, was diagnosed with menopausal symptoms and was treated with Combipatch. After drug was administered, patient experienced the following side effects: atrophic vulvovaginitis, breast cancer in situ, cervical dysplasia, cervicitis, cluster headache, hot flush, insomnia, malignant breast lump removal, mastectomy
. Combipatch dosage: 0.5 /0.14 MG/DAY, TIWCE WEEKLY. During the same period patient was treated with PREMPRO, PREMARIN, PROVERA. Patient recovered.Combipatch Side Effects Report #5699705-4
Combipatch side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 01, 2008. Female patient, 52 years of age, was diagnosed with menopausal symptoms and was treated with Combipatch. After drug was administered, patient experienced the following side effects: atrophic vulvovaginitis, breast cancer in situ, cervical dysplasia, cervicitis, cluster headache, ear pain, hot flush, insomnia, malignant breast lump removal. Combipatch dosage: 0.5 /0.14 MG/DAY, TIWCE WEEKLY. During the same period patient was treated with PREMPRO, PREMARIN, PROVERA. Patient recovered.
Combipatch Side Effects Report #5780255-1
Combipatch side effect was reported by a Consumer or non-health professional from UNITED STATES on June 16, 2008. Female patient, weighting 115.0 lb, was diagnosed with menopausal symptoms and was treated with Combipatch. After drug was administered, patient experienced the following side effects: atrophic vulvovaginitis, breast cancer in situ, cervical dysplasia, cervicitis, cluster headache, ear pain, hot flush, hyperaesthesia, hypoaesthesia. Combipatch dosage: 0.5 /0.14 MG/DAY, TIWCE WEEKLY. During the same period patient was treated with PREMPRO, PREMARIN, PROVERA. Patient recovered.